Catamount Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$65K Hold
500
0.04% 78
2018
Q4
$60K Hold
500
0.04% 65
2018
Q3
$54K Hold
500
0.03% 79
2018
Q2
$51K Hold
500
0.02% 77
2018
Q1
$39K Hold
500
0.02% 85
2017
Q4
$42K Hold
500
0.02% 84
2017
Q3
$43K Hold
500
0.03% 83
2017
Q2
$41K Hold
500
0.03% 94
2017
Q1
$42K Hold
500
0.03% 85
2016
Q4
$37K Hold
500
0.03% 76
2016
Q3
$41K Sell
500
-200
-29% -$16K 0.04% 73
2016
Q2
$55K Hold
700
0.06% 47
2016
Q1
$50K Sell
700
-206
-23% -$15.6K 0.06% 49
2015
Q4
$76K Buy
906
+206
+29% +$17.1K 0.07% 39
2015
Q3
$59K Hold
700
0.06% 44
2015
Q2
$58K Hold
700
0.04% 63
2015
Q1
$51K Buy
+700
New +$49.8K 0.04% 60

Other funds holding LLY

Catamount Wealth Management's LLY Position: Q1 2019 in Review

Catamount Wealth Management held its Eli Lilly (LLY) position steady in Q1 2019 at 500 shares worth $65K. The position accounts for 0.04% of the portfolio, ranked #78.

Catamount Wealth Management first reported a position in LLY in Q1 2015 and has held it in 17 quarters since. The position peaked at $76K in Q4 2015. 1,604 funds tracked by Wall St. Rank hold LLY as of Q1 2019.

  • Catamount Wealth Management held 500 shares of Eli Lilly worth $65K as of Q1 2019.
  • Catamount Wealth Management left its Eli Lilly share count unchanged in Q1 2019.
  • Eli Lilly made up 0.04% of Catamount Wealth Management's portfolio in Q1 2019, its #78 holding.
  • Catamount Wealth Management first reported a position in Eli Lilly in Q1 2015 and has held it in 17 quarters since.
  • Catamount Wealth Management's Eli Lilly position peaked at $76K in Q4 2015.
  • 1,604 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.

Based on Catamount Wealth Management's 13F filing for Q1 2019, filed 3 May 2019.